SC21 Team
Bio-Pharmaceutical Organization
Bringing cutting-edge biotechnology and innovative pharmaceutical products to the world
Nicholas Boyd-Gibbins, MEng, PhD
- Chief Scientific Officer, SC21 Bio-Pharma Laboratories (2023-present)
- Chief Scientific Officer, Therabest Japan (2022-2023)
- Scientific Director, StemCells21 (2020-2021)
- Postdoctoral Researcher, Department of Clinical Application, CiRA, Kyoto University
- PhD in Molecular Neuroscience, Faculty of Brain Sciences, University College London
- MEng in Bioengineering, Queen Mary University, London
Bio:
Nicholas is a scientist and bioengineer who has been leading industry R&D, translational, and biomanufacturing projects since 2020 as a Scientific Director, Head of Research, and Chief Scientific Officer in Thailand, Korea and Japan.
Originally training as a bioengineer at Queen Mary University, London, Nicholas first worked on iPSC engineering and epigenetic engineering in 2011. He then completed his PhD in molecular neuroscience at the Faculty of Brain Sciences, University College London, focusing on genetic and protein homeostasis, regeneration and ageing. He then worked as a postdoc in the Department for Clinical Application at the Centre for iPSC Research and Application (CiRA), Kyoto University, where he worked on stem cell and iPSC engineering, epigenetic engineering, cancer modeling, organoids, and neural stem cells.
His skills focus on team building, long-term strategic planning, translational pipeline design, biomanufacturing, cell engineering, iPSC technology, regenerative medicine, immunology, immunotherapy, cell therapy, stem cell biology, genetics, disease modeling, aging, cancer and neuroscience.
Dr. Thanakorn Pungsrinont (Map) PhD
Scientific and Manufacturing Director
Dr. Thanakorn Pungsrinont (Map) PhD
Scientific and Manufacturing Director
A small river named Duden flows by their place and supplies it with the necessary
- Phone:+1 (859) 254-6589
- Email:[email protected]
Apiwat Phitakpattanakul (Ta) B.Sc
Bio-Pharma Production
Apiwat Phitakpattanakul (Ta) B.Sc
Bio-Pharma Production
- B.Sc. (Biology) Chulalongkorn University
Previous specialized fields:
Forensic science
Pathology
Parasitology
- Phone:+6626507709
- Email:[email protected]
Chonchanok Promnont ( Noonee) B.Sc
Bio-Pharma Production
Chonchanok Promnont ( Noonee) B.Sc
Bio-Pharma Production
- Bachelors in Biochemistry from Khon Kaen University
- 3 years of experience in Stem Cells and Cancer Cells
- Phone:+6626507709
- Email:[email protected]
Suttinee kummanochat (Ploy)
Production Assistant
Suttinee kummanochat (Ploy)
Production Assistant
-Laboratory Assistant
-Biology Graduate
- Phone:+6626507709
- Email:[email protected]
SC21 Founders
Paul Collier
Co-Founder & Managing Director
Paul Collier
Co-Founder & Managing Director
Mr. Paul Collier is the founding partner of StemCells21 Company which has successfully launched various bio-tech projects and medical facilities in south-East Asia.
The newly established SC21 bio-pharma laboratories are in the highest category standard within this industry. The facility will research, develop and commercialize cutting edge biologic therapeutics.
- Phone:+6626507709
- Email:[email protected]
Sergejs Dmitrijevs
Co-Founder